Fever-Tree’s US partnership supports growth as the UK returns to expansion
Fever-Tree ($FEVR) reported adjusted brand revenue of £183.6 million in the first half, an 8% increase at constant exchange rates. US revenue grew 11% on the same basis as its Molson Coors partnership gained momentum, while the UK returned to growth. Adjusted EBITDA rose 9% to £20.1 million despite a step-up in US marketing spending. Diversification beyond tonic continued to matter: the wider portfolio grew 13% and now represents almost half of group sales. Management left its full-year expectat
0